Skip to main content
Carl Asche Headshot

Carl Asche, MBA, MSc, PhD

Academic Information

Departments Executive Director of PORC - College of Pharmacy , Research Professor - Pharmacotherapy

Academic Office Information

carl.asche@pharm.utah.edu

801-587-9119

Carl V. Asche, MBA, MSc, PhD, is currently the a Research Professor in the Department of Pharmacotherapy at the University of Utah College of Pharmacy in Salt Lake City and Executive Director of the Department's Pharmacotherapy Outcomes research Center. He also serves as the Director of the Post-Doctoral Fellowship Program in the Department of Pharmacotherapy along with appointments as Research Service WOC employee, Veteran's Affairs, Salt Lake City Healthcare System and Associate Member, Cancer Control and Population Science Research Program at the Huntsman Cancer Institute. His Research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of authoring and co-authoring over 150 peer-reviewed publications appearing in medical and economic literature. He serves on numerous national and international health economics-focused boards and committees, including editorial, grant review and advisory bodies. Dr. Asche's current research is funded by a variety of federal agencies and pharmaceutical companies. He earned his PhD (Economics) from the University of Surrey, MSc (Health Economics) from the University of York, and MBA from the City University of Seattle.

 

COURSES TAUGHT

  • PCTH 6125 Cost-Effectiveness, Validation of Economic Models, Lecturer

SERVICE

Department

  • Member, Pharmacotherapy Career-Line Faculty Review Committee

College

  • Member, Research Incentive Seed Grant Proposals Review Committee

University

  • Vice-Chair, Data Science Services Academic Oversight Committee

National

  • Member and Deputy-Chair, Guidelines and Economists Network International (GENI) Board
  • Member, Work Stream 2 Working Group, Project on Equity and Financial Toxicity (CancerX)
  • Member, Work Stream 3 Working Group, Impact Modeling (CancerX)

AWARDS AND HONORS

  • 2022 International Society of Pharmacoeconomics and Outcomes Research Service Award

RELATED LINKS

FAR webpage

Research Lab

College of Pharmacy

Education History

Doctoral Training University of Surrey
PhD (Economics)
MSc (Health Economics)

Selected Publications

Journal Article

  1. Asche C, Demeunynck M. Antitumor carbazoles. Anticancer Agents Med Chem. 2007 Mar;7(2):247-67. doi: 10.2174/187152007780058678 PMID: 17348830

  2. Asche C. Antitumour quinones. Mini Rev Med Chem. 2005 May;5(5):449-67. doi: 10.2174/1389557053765556. PMID: 15892687

  3. Asche CV, Kim M, Brown A, Golden A, Laack TA, Rosario J, Strother C, Totten VY, Okuda Y. Communicating Value in Simulation: Cost-Benefit Analysis and Return on Investment. Acad Emerg Med. 2018 Feb;25(2):230-237. doi: 10.1111/acem.13327. Epub 2017 Nov 30. PMID: 28965366 

    More Selected Publications